Condition: Schizophenia Disorder · Sponsor: Northwell Health
This study is recruiting participants who are experiencing a first episode of psychosis and who have certain genetic factors that may make them respond better to certain medications that are used to treat people with psychosis.
This description comes directly from the study's public registry record.
Patricia Marcy · 904-302-0811 · pmarcy@northwell.edu
Cristina Gonzalez · 347-804-3605 · cgomes@northwell.edu
Always discuss trial participation with your own doctor first.
| The University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| University of California San Diego | La Jolla, California, United States | Recruiting |
| McLean | Belmont, Massachusetts, United States | Recruiting |
| Feinstein Institute for Medical Research | Glen Oaks, New York, United States | Recruiting |
| Centre for Addiction and Mental Health | Toronto, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06969755